MedPath

Apelin estimation in periodontitis patients with obesity and type 2 diabetes

Not Applicable
Conditions
Health Condition 1: E660- Obesity due to excess caloriesHealth Condition 2: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2019/02/017522
Lead Sponsor
Panineeya institute of dental sciences and research centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with BMI 30.0 â?? 39.0 kg/m2 for group 2. (Centers for Disease Control and Prevention)

Patients previously diagnosed with T2DM and under medication were confirmed by their glycated haemoglobin (HbA1c: 6.5% - 8.5 --ADA,2017)

Patients with at least 15 natural teeth remaining.

Patients suffering from chronic periodontitis (>= 5mm pocket depth or >= 3mm loss of attachment) were selected. (Update to 1999 Disease Classification-AAP)

Patients who have not received periodontal therapy, within preceding six months.

Exclusion Criteria

Patients having aggressive periodontitis.

Patients having any other systemic diseases.

Patients with BMI > 40 kg/m2.

Patients with HbA1c > 8.5%.

Patients taking high-dose steroid therapy, radiation or immunosuppressive therapy.

Pregnant and lactating woman.

History of smoking within the past five years.

Mentally retarded and un-cooperative patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
serum and salivary apelin levelsTimepoint: baseline
Secondary Outcome Measures
NameTimeMethod
no secondary outcomesTimepoint: not applicable
© Copyright 2025. All Rights Reserved by MedPath